TK-666

N/A

Report date: 2024/12/03 15:10:08

NME

Base Information

Drug NameTK-666

Drug Alias NameTK-666

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionThymidylate kinase inhibitors

TargetsThymidylate kinase

Therapy Area/IndicationsBacterial Infections

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesAstrazeneca Plc

China Registration ClassN/A

Active CompaniesAstrazeneca Plc

Inactive CompaniesN/A

Active IndicationsBacterial Infections

Inactive IndicationsN/A

ATC CodeN/A